Anti‑inflammatory and anti‑catabolic effect of non‑animal stabilized hyaluronic acid and mesenchymal stem cell‑conditioned medium in an osteoarthritis coculture model

Mol Med Rep. 2020 May;21(5):2243-2250. doi: 10.3892/mmr.2020.11004. Epub 2020 Feb 26.

Abstract

Previous clinical studies have reported the clinical effectiveness of non‑animal stabilized hyaluronic acid (NASHA) and adipose‑derived mesenchymal stromal/stem cells (MSC) in the treatment of knee osteoarthritis (OA). Unlike MSC secreted mediators, in vitro anti‑inflammatory effects of NASHA have not been evaluated. We aimed to evaluate and compare the anti‑inflammatory effect of NASHA and MSC conditioned medium (stem cell‑conditioned medium; SC‑CM), in an explant‑based coculture model of OA. Cartilage and synovial membrane from seven patients undergoing total knee arthroplasty were used to create a coculture system. Recombinant IL‑1β was added to the cocultures to induce inflammation. Four experimental groups were generated: i) Basal; ii) IL‑1β; iii) NASHA (NASHA + IL‑1β); and iv) SC‑CM (SC‑CM + IL‑1β). Glycosaminoglycans (GAG) released in the culture medium and of nitric oxide (NO) production were quantified. Gene expression in cartilage and synovium of IL‑1β, matrix metallopeptidase 13 (MMP13), ADAM metallopeptidase with thrombospondin type 1 motif 5 (ADAMTS5) and tissue inhibitor of metalloproteinases 1 (TIMP1) was measured by reverse transcription‑quantitative PCR. Media GAG concentration was decreased in cocultures with NASHA and SC‑CM (48 h, P<0.05; 72 h, P<0.01) compared with IL‑1β. Production of NO was significantly lower only in SC‑CM after 72 h (P<0.01). In cartilage, SC‑CM inhibited the expression of IL‑1β, MMP13 and ADAMTS5, while NASHA had this effect only in MMP13 and ADAMTS5. In synovium, SC‑CM decreased the expression level of MMP13 and ADAMTS5, while NASHA only decreased ADAMTS5 expression. Both NASHA and SC‑CM increased TIMP1 expression in cartilage and synovium. Treatments with NASHA and SC‑CM were shown to be a therapeutic option that may help counteract the catabolism produced by the inflammatory state in knee OA. The anti‑inflammatory mediators produced by MSC promote a lower expression of inflammatory targets in our study model.

Keywords: hyaluronic acid; mesenchymal stem cells; cartilage; synovium; osteoarthritis.

MeSH terms

  • ADAMTS5 Protein / genetics
  • ADAMTS5 Protein / metabolism
  • Adipose Tissue / cytology
  • Adipose Tissue / metabolism
  • Aged
  • Anti-Inflammatory Agents / pharmacology*
  • Cartilage / drug effects*
  • Cartilage / metabolism
  • Cartilage / pathology
  • Cell Differentiation / drug effects
  • Chondrocytes / cytology
  • Chondrocytes / metabolism
  • Coculture Techniques
  • Culture Media, Conditioned / pharmacology*
  • Gene Expression Regulation / drug effects
  • Gene Expression Regulation / genetics
  • Glycosaminoglycans / metabolism
  • Humans
  • Hyaluronic Acid / pharmacology*
  • Inflammation / genetics
  • Inflammation / metabolism
  • Interleukin-1beta / genetics
  • Interleukin-1beta / pharmacology
  • Male
  • Matrix Metalloproteinase 13 / genetics
  • Matrix Metalloproteinase 13 / metabolism
  • Mesenchymal Stem Cells / metabolism*
  • Middle Aged
  • Nitric Oxide / metabolism
  • Osteoarthritis, Knee / genetics
  • Osteoarthritis, Knee / metabolism*
  • Recombinant Proteins / genetics
  • Recombinant Proteins / pharmacology
  • Synovial Membrane / metabolism*
  • Tissue Inhibitor of Metalloproteinase-1 / genetics
  • Tissue Inhibitor of Metalloproteinase-1 / metabolism

Substances

  • Anti-Inflammatory Agents
  • Culture Media, Conditioned
  • Glycosaminoglycans
  • IL1B protein, human
  • Interleukin-1beta
  • Recombinant Proteins
  • TIMP1 protein, human
  • Tissue Inhibitor of Metalloproteinase-1
  • Nitric Oxide
  • Hyaluronic Acid
  • ADAMTS5 Protein
  • ADAMTS5 protein, human
  • MMP13 protein, human
  • Matrix Metalloproteinase 13